Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Limited has announced the issuance of 817,434 new shares under its Employee Incentive Plan and Loan Funded Share Plan, which are now available for secondary trading in accordance with the exemptions of the Corporations Act. The company confirms compliance with the Act’s disclosure requirements and asserts that all necessary information for informed assessment by investors is current and available. Biome Australia specializes in the development and distribution of innovative probiotics and complementary medicines, aiming to enhance health outcomes globally.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.
